0001493152-24-033549.txt : 20240822 0001493152-24-033549.hdr.sgml : 20240822 20240822155715 ACCESSION NUMBER: 0001493152-24-033549 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240725 FILED AS OF DATE: 20240822 DATE AS OF CHANGE: 20240822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Perego Kenneth II CENTRAL INDEX KEY: 0001840012 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-56151 FILM NUMBER: 241231901 MAIL ADDRESS: STREET 1: 4704 COLLINGSBURG DR. CITY: ALEXANDRIA STATE: LA ZIP: 71303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: One World Products, Inc. CENTRAL INDEX KEY: 0001622244 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 611744826 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6605 GRAND MONTECITO PKWY STREET 2: SUITE 100 CITY: LAS VEGAS STATE: NV ZIP: 89149 BUSINESS PHONE: 7026050605 MAIL ADDRESS: STREET 1: 6605 GRAND MONTECITO PKWY STREET 2: SUITE 100 CITY: LAS VEGAS STATE: NV ZIP: 89149 FORMER COMPANY: FORMER CONFORMED NAME: One World Pharma, Inc. DATE OF NAME CHANGE: 20190125 FORMER COMPANY: FORMER CONFORMED NAME: PUNTO GROUP, CORP. DATE OF NAME CHANGE: 20141014 4 1 ownership.xml X0508 4 2024-07-25 0 0001622244 One World Products, Inc. OWPC 0001840012 Perego Kenneth II 6605 GRAND MONTECITO PKWY., SUITE 100 LAS VEGAS NV 89149 1 0 0 0 0 Common Stock 7000000 I See footnote Common Stock 5785000 D Series A Preferred Stock 2024-07-25 4 A 0 15000 150000 A 2024-07-25 Common Stock 1500000 2600000 I See footnote Warrants to Purchase Common Stock 0.25 2024-07-25 4 A 0 1500000 0.00 A 2024-07-25 2029-07-25 Common Stock 1500000 2050000 I See footnote 15,000 shares of Series A Preferred Stock and a Warrant to Purchase Common Stock of the Issuer were purchased, in units, by the Reporting Person for $150,000 in cash. Each share of Series A Preferred Stock is convertible at any time, at the Reporting Person's election, into 100 shares of the Issuer's common stock and has no expiration date Each share of Series A Preferred Stock is convertible at any time, at the election of the Reporting Person, into 100 shares of common stock of the Issuer. The Warrant to Purchase Common Stock is exercisable at any time, at the election of the Reporting Person, at an exercise price of $0.25 per share. Owned of record by Perego Trust, of which the Reporting Person is Trustee. Owned of record by CB Medical, LLC, of which the Reporting Person is the owner. All of the purchase price was allocated to the shares of Series A Preferred Stock. The Reporting Person beneficially owns a total of 17,785,000 shares of common stock of the Issuer. This is a late Form 4 filing. /s/ Dr. Kenneth Perego, II, M.D. 2024-08-22